Blue Apron Holdings Inc Class A, Inst Holders, 1Q 2018 (APRN)

4/19/18, 03:42
The following table shows the largest shareholders in BLUE APRON HOLDINGS INC CL A (APRN) for the quarter ended March 31, 2018, listed by holding size. The list represents up to 50 of the largest holders in the company.

Note: Unless otherwise mentioned the reporting date is 03/31/2018

Institution Shares Shares % Last
Held Changed Held Report


JPMorgan Investment Management 3,956,014 (62,626) 9.967 12/31

The Vanguard Group Inc.
2,374,594 363,845 5.982 12/31

River & Mercantile Asset Manag 2,222,005 1,183,136 5.598 12/31

Wellington Management Co. LLP 1,308,511 1,308,511 3.297 12/31

OZ Management LP 765,000 765,000 1.927 12/31

Group One Trading LP 760,096 539,376 1.915 12/31

BlackRock Fund Advisors 627,017 68 1.580 12/31

BT Investment Management Ltd. 576,324 363,044 1.452 12/31

Mizuho Securities USA LLC 300,000 300,000 0.756 12/31

Merrill Lynch Pierce Fenner 294,976 214,476 0.743 12/31

Lombard Odier Asset Management 175,000 175,000 0.441 12/31

Balyasny Asset Management LP 166,365 166,365 0.419 12/31

Geode Capital Management LLC 156,799 44,602 0.395 12/31

Stifel Nicolaus & Co. Inc. (I 147,414 (500) 0.371 12/31

Citadel Advisors LLC 127,014 (183,473) 0.320 12/31

SG Americas Securities LLC 126,296 126,296 0.318 12/31

Barclays Capital Inc. 126,042 18,942 0.318 12/31

JPMorgan Asset Management (UK) 121,006 0 0.305 12/31

The Public Sector Pension Inve 100,000 100,000 0.252 12/31

Jane Street Capital LLC 99,936 43,315 0.252 12/31

Goldman Sachs & Co. LLC (Priva 76,878 44,157 0.194 12/31

JPMorgan Chase Bank NA (Inves 71,206 (1,144) 0.179 12/31

Raymond James Financial Servic 65,054 65,054 0.164 03/31

Northern Trust Investments In 54,908 (583) 0.138 12/31

Citigroup Global Markets Inc. 51,452 44,077 0.130 12/31

Veritable LP 49,500 12,500 0.125 12/31

Cubist Systematic Strategies L 43,519 43,519 0.110 12/31

Virtu Financial BD LLC 42,998 (11,186) 0.108 12/31

Susquehanna Financial Group LL 41,088 41,088 0.104 12/31

Morgan Stanley Smith Barney LL 37,597 (5,953) 0.095 12/31

Eagle Asset Management Inc. 37,469 15,000 0.094 03/31

SSgA Funds Management Inc. 35,400 0 0.089 12/31

Wells Fargo Bank NA (Private 28,443 (54,037) 0.072 12/31

Deutsche Bank Securities Inc. 23,329 23,329 0.059 12/31

The Bank of New York Mellon Co 21,304 (700) 0.054 12/31

Jefferies Investment Advisers 20,000 (583,911) 0.050 12/31

Analytic Investors LLC 17,566 17,566 0.044 12/31

RBC Capital Markets LLC (Inves 17,148 (11,280) 0.043 12/31

UBS Financial Services Inc. 14,005 7,900 0.035 12/31

G1 Execution Services LLC 13,580 13,580 0.034 12/31

Walleye Trading Advisors LLC 13,064 13,064 0.033 12/31

Wolverine Trading LLC 12,365 (10,959) 0.031 12/31

Brave Asset Management Inc. 12,000 12,000 0.030 12/31

Kovack Advisors Inc. 11,000 11,000 0.028 12/31

Tower Research Capital LLC 10,472 10,252 0.026 12/31

BNY Mellon Capital Markets LLC 9,976 9,976 0.025 12/31

Vanguard Fiduciary Trust Co. 8,073 7,850 0.020 12/31

Macquarie Funds Management Hon 7,800 7,800 0.020 12/31

Woodbury Financial Services I 6,515 3,500 0.016 12/31

Manulife Asset Management Ltd. 5,479 75 0.014 12/31

13F data provided by: Factset Research Systems Inc.;
Please send questions to ownership@factset.com.
Copyright, Factset Research Systems, 2018. All Rights Reserved.


(END) Dow Jones Newswires
04-19-18 0342ET

Total Supply: 100,000,000 QTH

Token Balance: 99,800,000 QTH
Token Value: $0.00 (99.8000%)


Not sure what that means exactly...

Value:
0 Ether ($0.00)
Gas Limit:
250000
Gas Used By Txn:
66972
Gas Price:
0.000000004 Ether (4 Gwei)
Actual Tx Cost/Fee:
0.000267888 Ether ($0.14)
Nonce:
60

Value:
0 Ether ($0.00)
Gas Limit:
76929
Gas Used By Txn:
51286
Gas Price:
0.000000001 Ether (1 Gwei)
Actual Tx Cost/Fee:
0.000051286 Ether ($0.03)
Nonce:
63

What’s that worth?

20,000,000,000 A/S @ .0001 is $2,000,000. Company only makes $1,200,000 with $1,400,000 of debt.

Doubled debt and doubled A/S...

QuantH has a ways to go before it’s worth anything to attract the large investors...

Early investing isn’t working, discounted investing isn’t working, all these silent hyped investors don’t seem to be there...

Should have stuck to the ambulance company until things were stable and debt free, then moved into this block chain thing...

Still no ‘substantiated’ reason for the original filings and audits to not have been done by now...

QuantH (QTH) ICO Medical Blockchain Technology UpdatePress Release | 04/18/2018
Sugar land, Texas April 18, 2018-Quantum Medical Transport, Inc. (DRWN: OTC.PK)


QuantH (QTH) ICO Medical Blockchain Technology Update




Quantum Medical Transport, Inc. (DRWN: OTC.PK) management wanted to take this opportunity to update our shareholders regarding recent developments and company plans. We are committed to improving the direction of the company share price. We are committed to share repurchase as a method to restructure the share structure. We ask our stakeholders to be patient while we work to reach our vision. Our ICO is beginning to see light in the capital raise with the listing of our token on EtherDelta https://etherdelta.com/#0xbbc7b05e8b4b5fc4e2de3dd9eee044d44bba9f5d-ETH . Our investors can track our tokens on https://etherscan.io/token/0xbbc7b05e8b4b5fc4e2de3dd9eee044d44bba9f5d

Interested parties can join the ICO through visiting our website: www.quanth.io to participate you simply must have an Ethereum wallet such as Metamask.io or Coinbase setup an account, deposit funds, then go to EtherDelta select account import, transfer deposit and select buy QTH.

View abstract provisional patent application filed on our website and clicking this link: https://nebula.wsimg.com/d1bf519d9dd2ca7a4b065cee8d7cece6?AccessKeyId=40BD460D4BEAC51546AB&disposition=0&alloworigin=1

We believe we will improve our market position, revenue, share price and build a great company with strong value in the near future. We are pleased to release a copy of our provisional patent application for QuantH Medical Blockchain Technology V1.0, this brings considerable IP value to our company as the frontrunner in this space, say Ricky Bernard, CEO.

We believe we are the front runner with our intellectual property and others will need to license our technology in the healthcare eco system to utilize it. The value will be in our IP and we mentioned seeing some large players such as Google (GOOGL), Amazon (AMZN) and Apple (APPL) who have been buying medical blockchain technology companies, developing IOT and acquiring patents. These global techno behemoths are still targeting the healthcare industry as the new wave of revenue stream in patient information management. Apples CEO Tim Cook said in his keynote in September 2017, healthcare is big for Apples future. In fact in with over $7 trillion in health spending per year, its already almost 10% of global GDP. Apple acquired digital health company Glimpse and has partnered with Health Gorilla, the company is slowly shifting to offering a full personal health record.

Amazon Web Services (AWS), the companys cloud business, partnered with healthcare tech giant Cerner in November 2017 to help medical providers use their data to make effective health predictions. Amazon new job posting for experienced Medical Blockchain Technology expert is a clear sign.



About Quantum Medical Transport/United Ambulance/QuantH

QUANTUM MEDICAL TRANSPORT, INC. /UNITED AMBULANCE, LLC is a medical technology and transportation company. The company is developing a proprietary medical blockchain technology for secure data storage and data transfer in a HIPPA compliant manner. We also provide emergency and non-emergency medical transportation services in the State of Texas. The Company provides basic and advanced life support ground transport in an emergency and non-emergency setting, 24 hours a day, and seven days a week.The Company makes both local and regional out-of-town services available on a daily dispatch basis.

Management remains focused on providing prompt, high-quality patient care at the Advanced and Basic Life Support levels. Employees will work diligently to achieve goals while maintaining the highest standards of care.

CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements that involve a number of risks and uncertainties.Forward-looking statements generally can be identified by the use of forward-looking terminology such as believes, expects, may, will, intends, plans, should, seeks, pro forma, anticipates, estimates, continues, or other variations thereof (including their use in the negative), or by discussions of strategies, plans or intentions.A number of factors could cause results to differ materially from those anticipated by such forward-looking statements, including those discussed under Risk Factors and Our Business. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements.Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons.



Investor Relations:

Ricky Bernard

832-436-1831 x100

info@quantummedicaltransport.com

www.quantummedicaltransport.com

www.quantH.io (ICO Website)

Follow us on twitter@quantummedical1

Bluegreen Vacations (BXG +3%) announces the acquisition of The Éilan Hotel and Spa in San Antonio, Texas for ~$34.3M.
• "This acquisition reflects our ability to identify attractive opportunities in key markets aligned with our western expansion initiatives, and is an important addition to our resort portfolio," says Bluegreen CEO Shawn Pearson.
• The company aplans to add a 13K square foot sales office at the resort by year end, which Bluegreen believes will expand its footprint for new business prospects and owner growth.
• The acquisition is also seen further leveraging Bluegreen's existing marketing platforms, which include the seven Bass Pro Shops located in Texas, as well as its recently extended relationship with Choice Hotels.

Tue, Apr 17, 2018 12:00 - Omagine, Inc. (OMAG: Pink Current) - Tier Change - The symbol, OMAG, no longer is classified as OTCQB. As of Tue, Apr 17, 2018, OMAG resides in the Pink Current tier. You may find a complete list of tier changes at otcmarkets.com.

So much for those restrictions!!!

Northbridge Financial has a leak out provision of 50 Million shares per day and is further limited by their clearing firm to trading restrictions of 3 days per week.

https://backend.otcmarkets.com/otcapi/company/financial-report/190409/content

$DRWN Northbridge Financial crushed the sp getting out of their position because Alpine is not clearing subpenny in trips anymore after today. No more debt conversions under the 3(a)10 for now. Maybe now price recovery can happen.

$DRWN Northbridge Financial crushed the sp getting out of their position because Alpine is not clearing subpenny in trips anymore after today. No more debt conversions under the 3(a)10 for now. Maybe now price recovery can happen.

— Quantum Medical (@Quantummedical1) April 13, 2018

$DRWN “In our opinion now is the time for dollar-cost-averaging for those long players.”

https://globenewswire.com/news-release/2018/04/11/1468314/0/en/Quantum-Medical-Files-Patent-for-HIPAA-Compliant-Blockchain-and-Updates-Shareholders.html

$DRWN The Company announces there will be “No Reverse Split”.

https://twitter.com/quantummedical1/status/984047815277121537?s=21

$DRWN QuantH Tokens trading on EtherDelta etherdelta.com/#0xbbc7b05e8b4…
Join Now to support Medical Blockchain
#ICO #cryptocurrency #ETH #Ethdelta #Medical #technology #blockchain

I dunno what do you have here ;)

Better yet browse through the lawsuit dates of previous ticker and see when the aliases here were born and have posted non stop since... coincidence?

Exactly. More details, more awareness, more distribution, and more sales...

Possibly... the March PR at least stated the product.

Last Shot Premium hydration drink is an all-natural beverage for anyone, anytime. In the morning, when your body struggles to find energy, Last Shot gives you the boost you need to perform at that key meeting, have that intense workout, or detoxify from the night before. The 2-PM slump is non-existent because Last Shot’s refreshing cranberry-raspberry flavor blends seamlessly with B-6, B-12 and other natural ingredients to provide a refreshing taste. Last Shot Premium hydration drink comes in a convenient 8.6 ounce can.

Agreed!!! Less about googlable info on Kevin and more about the relationship with EQ Labs...

Partnership? Advisor? Equity stake?
Shares for services? Royalties?

Anyone not up to date just reads that PR about Kevin that says nothing about EQ Labs other than “brings his sales and marketing expertise”.

Which that may be all it needs is a name and an infamous face to put on some advertising however I’m sure investors would like more detail...

Either way this will move today :)

Just my opinion of course...

EQ Labs Inc. Announces: original "Shark" Kevin Harrington from SHARK TANK been able to more than 10 X the stock price of several public companies and brings his sales and marketing expertise to EQ Labs, Inc.

Kevin Harrington has been a successful entrepreneur over the last 40 years. He is an Original Shark on the ABC hit, Emmy winning TV show, "Shark Tank." He is also the Inventor of the Infomercial, As Seen on TV Pioneer, Co- Founder of the Electronic Retailers Association (ERA) and Co- Founder of the Entrepreneurs' Organization (EO). Kevin has launched over 20 businesses that have grown to over $100 million in sales each, has been involved in more than a dozen public companies, and has launched over 500 products generating more than $5 billion in sales worldwide. Kevin has extensive experience in business all over the world, opening distribution outlets in over 100 countries worldwide.

Kevin currently operates a private consulting firm where he works with companies to increase distribution; analyze electronic retailing opportunities; effectively market on digital, social media, TV, radio, or print; source manufacturing; celebrity relationships; open his rolodex; and more has been able tos competitive world'In today 10 X the stock price of several public companies. than, companies cannot operate the way they have in the past because of the advancements in technology and the digital marketplace. Kevin provides the advice and expertise on how to navigate the constant changing distribution and marketing outlets. Kevin also brings his rolodex and relationships to all companies he works with, including help in financing, like he did with Celsius: http://www.bizjournals.com/southflorida/news/2015/04/21/celsius-lands-16m-celebrity-investment.html

Kevin got his start as a young entrepreneur in the early 80's when he invested $25,000 and launched Quantum International. This turned in to a $500 million per year business on the New York Stock Exchange and drove the stock price from $1 to $20 per share.

He is a co-founder of the EO (Entrepreneurs Organization), which has grown to 150 cities and 45 countries and thousands of members, generating over $500 Billion of member sales. In 1990 he co-founded the global direct to consumer organization and trade show, the Electronic Retailers Association (ERA). Today ERA is the exclusive trade association to represent a global $350-billion direct-to-consumer market place. What is more, Kevin's success has been chronicled in a case study at Harvard/MIT and has been taught there for over a decade.

To learn more about Kevin, please visit www.KevinHarrington.tv and watch this short video here:

Safe Harbor:

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements generally can be identified by phrases such as EQ Energy Drink, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new business opportunities and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.



Contact Information:

EQ ENERGY DRINK, Inc

Maurice Owens, President and CEO

Phone: (702) 806-5943

Web: www. drinklastshotlv.com

Email: mo@drinkeq.com

Sounds like it... not sure why repeated though it’s word for word... unless I’m missing something what are the additional documents?

April 11, 2018
OTC Disclosure & News Service

Los Angeles, CA —

This release includes additional documents. Select the link(s) below to view.

LOS ANGELES, CA / ACCESSWIRE / April 5, 2018 / Full Alliance Group, Inc. (OTC PINK: FAGI), a holding company, is pleased to announce that the Company has entered into an Agreement to acquire Kelevra Digital Solutions, S.A. de C.V. ("Kelevra"), a Mexico City-based custom software technology developer.

Kelevra's management team and experienced programmers/developers have conducted extensive operations within Mexico and have completed numerous custom software development projects for a diverse and growing client list which includes several multi-national corporations.

Full Alliance Group executives are very excited about the acquisition of these valuable assets, their growth potential, and their considerable synergies with other Full Alliance Group companies, particularly Kelevra's experience and success within the financial technologies (fintech) sector.

Under terms of the Agreement, Full Alliance Group may acquire up to 99% of Kelevra, including substantially all operations, technologies, and intellectual properties, in exchange for a combination of cash and stock. Upon completion of the proposed acquisition, Kelevra will operate as a subsidiary of the Company. The proposed acquisition is subject to customary conditions such as satisfactory completion of due diligence and regulatory approvals expected to take 60 days or less.

Full Alliance Group anticipates making several further announcements regarding the Kelevra acquisition as the current due diligence process moves forward.



Los Angeles, California – April 5, 2018 - Full Alliance Group, Inc. (OTCPK: FAGI), a holding company, is pleased to announce that the Company has entered into an Agreement to acquire Kelevra Digital Solutions, S.A. de C.V. (“Kelevra”), a Mexico City-based custom software technology developer.

Kelevra’s management team and experienced programmers/developers have conducted extensive operations within Mexico and have completed numerous custom software development projects for a diverse and growing client list which includes several multi-national corporations.
Full Alliance Group executives are very excited about the acquisition of these valuable assets, their growth potential, and their considerable synergies with other Full Alliance Group companies, particularly Kelevra’s experience and success within the financial technologies (fintech) sector.

Under terms of the Agreement, Full Alliance Group may acquire up to 99% of Kelevra, including substantially all operations, technologies, and intellectual properties, in exchange for a combination of cash and stock. Upon completion of the proposed acquisition, Kelevra will operate as a subsidiary of the Company. The proposed acquisition is subject to customary conditions such as satisfactory completion of due diligence and regulatory approvals expected to take 60 days or less.

Full Alliance Group anticipates making several further announcements regarding the Kelevra acquisition as the current due diligence process moves forward.

Full Alliance Group Acquires KelevraEntry into a Material Definitive Agreement | 04/11/2018
April 11, 2018
OTC Disclosure & News Service

Los Angeles, CA —

This release includes additional documents. Select the link(s) below to view.
FAGI - PR - Kelevra - 4-5-18.pdf


https://www.otcmarkets.com/stock/FAGI/news?id=188883

5.8mil volume out the gate!!!

If its not new, where'd all the shares come from in june 2017 that dumped this from .0005 to no bid and held it till Jan 2018?

'We have terminated our previous 3(a)10 agreement with Northbridge, severing our relationship with that group. We believe they have liquidated their positions.'
https://finance.yahoo.com/news/quantum-medical-transport-letter-shareholders-110000618.html

The excuse was Northbridge...now not so much...

'I know we have had some turbulence in our share price recently due to the 3(a)10 debt with Northbridge Financial which has reduced our debt by $108,000. However, this is not new debt and we vow to not issue any convertible toxic debt notes. We will not have this debt forever and the market valuation will rebound.'
https://www.otcmarkets.com/stock/DRWN/news/Quantum-Medical-Files-Patent-for-HIPAA-Compliant-Blockchain-and-Updates-Shareholders?id=188783

Sure its new debt because it was claimed that they liquidated their position, then in Oct claimed CF3 took it from $810,000 to $1,455,000.

CF3 releases $700,000 back to Northbridge? So we still owe $1,400,000 or how much is still owed to CF3?

So were these retired or given back to Northbridge since this was the exact number of shares they were supposedly given and diluted with the first time?
The company received 1,407,000,000 common shares were retired back to treasury thus reducing the number of outstanding shares.







$DRWN was originally going to do a 3(a)10 transaction with Northbridge Financial Inc in Sarasota County, Florida to pay off $750,000 in debt owed to Jason Peretek for the acquisition of United Ambulance LLC plus $60,000 owed to Windsor Street Capital LP for providing broker services for the transaction. DRWN had originally set aside 1,407,000,000 shares to issue to Northbridge Financial Inc (Samuel Oshana) towards the debt but the agreement was terminated on October 6, 2017 after it was decided that DRWN would instead do a 3(a)10 transaction with CF3 Enterprises LLC for the Jason Peretek debt plus a bunch of other debts/liablities.

On 09-29-2017 DRWN and CF3 Enterprises LLC did a prearranaged 3(a)10 transaction through the court in Broward County, Florida. According to the CF3 Enterprises LLC Complaint (which was too large for me to upload and share but is available to anybody at the Broward County court records website), CF3 Enterprises LLC paid off $1,451,000 in debts for DRWN

Quantum Medical Files Patent for HIPAA Compliant Blockchain and Updates ShareholdersPress Release | 04/11/2018
SUGAR LAND, TX , April 11, 2018 (GLOBE NEWSWIRE) -- Quantum Medical Transport, Inc., (OTC PINK: DRWN) Announces the filing of a patent for HIPAA updates shareholders regarding recent development and plans for the company moving forward.

Quantum Medical (OTC Pink: DRWN) management would like to take this opportunity to update our shareholders regarding recent developments and company plans as we enter Q2 2018 and move forward.

First of all, in the mist of this storm we have some exciting news “We will be filing our patent application this week for QuantH Medical Blockchain Technology V1.0. This HIPAA compliant technology is what sets us apart from other microcap companies in the space, and is sure to bring us to the next level as a leader in the medical blockchain space, stated Ricky Bernard, CEO”.

I know we have had some turbulence in our share price recently due to the 3(a)10 debt with Northbridge Financial which has reduced our debt by $108,000. However, this is not new debt and we vow to not issue any convertible toxic debt notes. We will not have this debt forever and the market valuation will rebound.

As a fellow stakeholder with you, we too are unhappy with the share price. In our opinion now is the time for dollar-cost-averaging for those long players. It is still our goal to raise enough capital through the ICO and have had talks regarding non-convertible preferred, coupon based equity, to pay invested in the further reduction of debt as well as the repurchase of our common shares in the open market.

We are committed to improving the direction of the Company’s stock price and overall shareholder valuation as we believe we will improve our position and build a great company with strong value in the near future.

We will be the front runner with our intellectual property and others will need to license our technology in the healthcare eco system. There is massive value in our IP and we are seeing some large players such as Amazon and Apple acquiring medical blockchain technology companies and patents.

These global techno behemoths are targeting the healthcare industry as a new revenue stream in patient information management. Apple’s CEO Tim Cook said in his keynote in September 2017, “healthcare is big for Apple’s future.” In fact in with over $7 trillion in health spending per year, it’s already almost 10% of global GDP. Apple acquired digital health company Glimpse and has partnered with Health Gorilla, the company is slowly shifting to offering a full personal health record.

Amazon Web Services (AWS), the company’s cloud business, partnered with healthcare tech giant Cerner in November 2017 to help medical providers use their data to make effective health predictions.

We would say the future of Quantum Medical Transportation, looks very bright in the grand spectrum of medical blockchain technology.

About Quantum Medical Transport/United Ambulance/QuantH

QUANTUM MEDICAL TRANSPORT, INC. /UNITED AMBULANCE, LLC is a medical technology and transportation company. The company is developing a proprietary medical blockchain technology for secure data storage and data transfer in a HIPPA compliant manner. We also provide emergency and non-emergency medical transportation services in the State of Texas. The Company provides basic and advanced life support ground transport in an emergency and non-emergency setting, 24 hours a day, and seven days a week. The Company makes both local and regional out-of-town services available on a daily dispatch basis.

Management remains focused on providing prompt, high-quality patient care at the Advanced and Basic Life Support levels. Employees will work diligently to achieve goals while maintaining the highest standards of care.

CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “believes,” “expects,” “may,” “will,” “intends, “plans,” “should,” “seeks,” “pro forma,” “anticipates,” “estimates,” “continues,” or other variations thereof (including their use in the negative), or by discussions of strategies, plans or intentions. A number of factors could cause results to differ materially from those anticipated by such forward-looking statements, including those discussed under “Risk Factors” and “Our Business.” Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons.

www.quantummedicaltransport.com

www.quantH.io (ICO Website)

Follow us on twitter@quantummedical1


Investor Relations:
Ricky Bernard
832-436-1831 x100
info@quantummedicaltransport.com

Of course it is... post split maybe that’s possible...

warrant to purchase 100,000 shares of common stock for each unit purchased exercisable for three years commencing six months from issuance with an exercise price at $0.60 during the initial year, $0.80 during the second year and $1.00 during the third and final year.

They are pumping again:
TXHD Alert: Exiting news as we grow our company with equity investment and no more convertible debt, click for details https://bit.ly/2Hc7RYY
reply STOP 2 stop

OTC Report | (OTC:DRWN) Full DD Report otc.report/reports/DRWN/
Shareholder update coming Wednesday April 11
#OTC #stocks #investors #investment

OTC Report | (OTC:DRWN) Full DD Report https://t.co/1aV7ZuqTT0
Shareholder update coming Wednesday April 11#OTC #stocks #investors #investment

— Quantum Medical (@Quantummedical1) April 10, 2018

GB Sciences Pursues FDA-Registered, First-in-Human Trial of Cannabis-based Therapy for Parkinson's Disease

LAS VEGAS, April 10, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies for the treatment of early to moderate Parkinson's disease ("PD"). The GB Sciences' Exploratory IND program is designed to allow the company to make informed, data-driven choices in selecting and prioritizing the development of multiple, related drug compositions and formulations. An Exploratory IND requires less pre-clinical data and offers a more flexible way to get essential information about potential drug development candidates than a more conventional early phase development program. Performing an FDA-Registered clinical trial, instead of a Nevada-based pilot trial as reported earlier, also translates to quicker entry into international markets with harmonized regulatory standards.

As previously reported, GB Sciences has pending US and International patent applications covering multiple, related PD-formulas based on complex mixtures of minor cannabinoids and terpenes from cannabis chemovars. In pre-clinical studies, these complex cannabis-based formulas both increased dopamine production and demonstrated potential neuroprotective properties. The disease processes targeted by GB Sciences' therapeutic mixtures are central to the progression of PD, as well as other related neurological conditions.

"The Exploratory IND/Phase 0 program allows companies to establish a clinical trial protocol to distinguish between multiple formulations based on various measures, including pharmacological and pharmacodynamic measures that may be predictive of efficacy, as well as measures that will help us assess the mechanism of action of our drug candidates," explains Dr. Andrea Small-Howard, Chief Science Officer of GB Sciences. "GB Sciences believes that its regulatory strategy can deliver enough data to allow us to select one or more optimal candidates for development, and do so more quickly and more efficiently than if we were to proceed directly to a traditional phased development program."

The company will begin its toxicology studies in the summer of 2018 in preparation for the Exploratory IND, but prior to receiving feedback from the US FDA to verify that the company's regulatory strategy and Phase 0 clinical trial protocol are acceptable to the agency. GB Sciences expects to commence its First-in-Human Trial in early 2019, pending FDA acceptance of their Exploratory IND application and proposed Phase 0 protocol.

GB Sciences is committed to providing evidence-based therapies to patients in markets beyond those reachable in state-regulated medical marijuana systems. While it may be more difficult to register the First-in-Human trial with the US FDA in the short term, the longer-term benefits for the patients and GB shareholders should be great.

"GB Sciences has always been committed to providing the highest quality therapies to patients, and working through US FDA channels will allow us to get these medicines to patients across the US and internationally quicker than just 'staying in our lane' in the less regulated state-run medical cannabis programs," said John Poss, CEO and Chairman of GB Sciences, Inc. "At GB, we know that doing the right thing may take a little longer, but the rewards are often greater."

About GB Sciences, Inc.

GB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company's goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about GB Sciences, Inc., go to: http://gbsciences.com.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Note: Although the Company's research and development activities are not illegal, the production and sale of cannabis products violate federal laws as they presently exist.

Contact Information

Corporate:

GB Sciences, Inc., 3550 West Teco Ave., Las Vegas, NV 89118
866-721-0297, or
Tom Arcuragi, EVP, tom@gbsciences.com



SOURCE GB Sciences, Inc.

Related Links

http://gbsciences.com/

Bluegreen Vacations Renews and Extends $50 million Timeshare Receivables Facility

Apr. 9, 2018 4:05 PM

BOCA RATON, Fla.--(BUSINESS WIRE)-- Bluegreen Vacations Corporation (NYSE: BXG) ("Bluegreen" or the “Company") today reported that on March 12, 2018, the Company amended and restated its revolving timeshare receivables hypothecation facility with Liberty Bank.
The restructured revolving credit period will now run through March 2020, maturing in March 2023.

This agreement did not impact the maximum permitted outstanding borrowing of $50 million, and as of March 12, 2018, only $22.8 million was outstanding under the facility. Commencing on April 1, 2018, the interest rate on the facility will decrease to the Prime Rate from the Prime Rate plus 0.50%, both subject to a floor of 4.00%.
Bluegreen plans to continue to use the facility to finance vacation ownership interest notes receivable.

"This extension to our agreement with Liberty Bank continues and improves a key element of our liquidity profile to fuel growth in our vacation ownership sales," commented Tony Puleo, Bluegreen Vacation's Executive Vice President and Chief Financial Officer.

"We value our longstanding relationship with Liberty Bank, and we believe this amended agreement will contribute to the ongoing success of our business model."
Don Peruta, Senior Vice President of Liberty Bank commented, “Liberty Bank is excited to continue our relationship with Bluegreen.
We are pleased to play a role in its ongoing success and remain committed to supporting the vacation ownership industry.”

About Bluegreen Vacations Corporation:
Bluegreen Vacations Corporation (NYSE: BXG) is a leading vacation ownership company that markets and sells vacation ownership interests (VOIs) and manages resorts in top leisure and urban destinations. The Bluegreen Vacation Club is a flexible, points-based, deeded vacation ownership plan with approximately 213,000 owners, 67 Club and Club Associate Resorts and access to more than 11,000 other hotels and resorts through partnerships and exchange networks as of December 31, 2017. Bluegreen Vacations (BXG) also offers a portfolio of comprehensive, fee-based resort management, financial, and sales and marketing services, to or on behalf of third parties. Bluegreen is 90% owned by BBX Capital Corporation (BBXTB) (NYSE: BBX) (OTCQX: BBXTB), a diversified holding company. For further information, visit www.BluegreenVacations.com.
About BBX Capital Corporation:
BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB), is a Florida-based diversified holding company whose activities include its 90% ownership interest in Bluegreen Vacations Corporation (NYSE: BXG) as well as its real estate and middle market divisions. For additional information, please visit www.BBXCapital.com.
Forward-Looking Statements:
Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements are based on current expectations of management and can be identified by the use of words such as “believe”, “may”, “could”, “should”, “plans”, “anticipates”, “intends”, “estimates”, “expects”, and other words and phrases of similar impact. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results or performance to differ from those set forth or implied by the forward-looking statements, including but not limited to, risks that the Company’s results or performance will differ from that expected, the risk that the terms for drawing on the facility will not be met, and the risk that the Company will not in the future be in compliance with applicable covenants and ratios required by the facility. For a description of other risks and uncertainties, please see the “Risk Factors” section of Bluegreen’s Annual Report on Form 10-K for the year ended December 31, 2017. Bluegreen cautions that the foregoing factors are not exclusive. You should not place undue reliance on any forward-looking statement, which speaks only as of the date made. Bluegreen does not undertake, and specifically disclaims any obligation, to update or supplement any forward-looking statements.
http://cts.businesswire.com/ct/CT?id=bwnews&sty=20180409005960r1&sid=acqr7&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20180409005960/en/
Bluegreen Vacations
Media Contact:
Jennifer Williams, 561-912-8266
Email: Jennifer.Williams@bluegreenvacations.com
Source: Bluegreen Vacations Corporation
Copyright Business Wire 2018

Been 6bil since July

https://wyobiz.wy.gov/business/GetImages.aspx?sid=052140135242148233181163196236133061123227236253&stid=143081052037131049174101151060105191121240225143

Not if I’m reading it correctly...

it sounds as if there’s now $2mil in debt and doubled the share structure...

$648,000 to North ridge
$1,455,000 to CF3 (which was supposed to pay off the Northridge debt)

Doubled the A/S to 20bil

And another 400,000,000 shares to a vender...

Yet has the gall to add: “We are currently raising capital to buy down and pay off the debt owed to our 3(a)10 debt holders, then continue our share repurchase to reduce the outstanding shares. “

The company entered into a settlement agreement with Northbridge Financial to restructure the company debt through a 3(a)10 lawsuit that was filed by Northbridge, in which Northbridge received stock in exchange for the debt. The $810,000 debt was incurred as a result of the acquisition of United Ambulance, LLC.

The company mutually terminated its 3(a)10 settlement agreement with Northbridge Financial and entered into a settlement with CF3 Enterprises, LLC a New York private equity firm that acquired the company’s total outstanding debt of $1,455,000 through a 3(a)10 settlement.


https://backend.otcmarkets.com/otcapi/company/financial-report/186063/content

Wow!!! What a lying worthless POS!!!

Wasn’t CF3 to buy out Northbridge debt of over $800k hence why CF3 was $1.4mil? Didn’t he state specifically they were done with them?


Sugar land, Texas April 07, 2018-Quantum Medical Transport, Inc. (DRWN: OTC.PK)
Quantum Medical Transport, Inc. Shareholders Disclosure

Quantum Medical Transport, Inc. (DRWN: OTC.PK) management wanted to take this opportunity to update our shareholders regarding the status of our 3(a)10 obligations, conversions and share structure.
We currently have two outstanding 3(a)10 debt settlements with Northbridge Financial and CF3 Enterprises as disclosed on our financial reports and disclosure statements. We wanted to present to our shareholder the status of these debt settlements and how it affects the share structure in the interest of transparency.

Northbridge Financial was owed $756,000 under the 3(a)10 settlement as of 4/09/18 the balance will have decreased to $648,000 based upon pay down of the outstanding debt in the amount of $108,000. Northbridge has received a total 330,400,000 shares in conversions of the total debt owed to them, which included $40,000 of debt and settlement shares. Northbridge Financial has a leak out provision of 50 Million shares per day and is further limited by their clearing firm to trading restrictions of 3 days per week.

We have had to increase our authorized shares from 10 Billion to 20 Billion to meet with our obligations under the 3(a)10 reserve agreements with CF3 Enterprises and Northbridge. We just filed an amendment to the articles of incorporation increasing the authorized shares. Northbridge has a reserve requirement of 5 Billion shares and CF3 has a reserve requirement of 3 Billion shares.
CF3 has not conducted any recent conversions and is current not selling any shares.

We have an obligation to issue 400 Million restricted shares to a vendor for services rendered which has not been issued yet. We are currently raising capital to buy down and pay off the debt owed to our 3(a)10 debt holders, then continue our share repurchase to reduce the outstanding shares.

Our current share structure is as follows: Authorized-20,000,000,000 Outstanding- 8,376,298,915
Restricted- 5,841,642,932 Float-2,424,655,983

We have submitted request to OTC Markets to update the share structure which usually takes 48 hours. We will continue to update and inform our shareholders.

TEVi

About us
It is an innovative system that is revolutionizing the traditional electronic payment means, TEVi guarantees the security of the information and personal data, making it an easy, safe and reliable system.

What is TEVi?
TEVi is a mobile payment platform, the only one of its type in Mexico, which allows the storage of bank cards, payment of services and transfer of money through a smartphone, complying with the highest standards of Banxico and CNBV transactions. Protect the money of Mexican cardholders.

How does TEVi work?
TEVi works like any electronic wallet, where you can place the data of your credit and debit cards, in a safe way; so that you can make transactions from the palm of your hand, without the need to present your (s) plastics with the risk of cloning cards.
Through a simple and friendly interface with the user, the payment of services is done securely by means of secure and transparent connections for the user. The hosting of the data of said cards is protected by servers certified by the Bank of Mexico and the National Banking and Securities Commission. With this, the users of TEVi can be sure that their data will be insured and nobody will have access to them.

At the moment of making a purchase with TEVi the user will have one of the six security elements (namely: alphanumeric code, pattern, touch ID - available in some equipment-, PIN, image, color code), which were defined at the time of Download the application. This ensures that no other person can occupy the stored cards, let alone misuse them. The transaction is made through a state-of-the-art Bluetooth device, which encrypts the information so that there are no intrusions, and the payment is made between the smartphone to the cash register of the establishment.

It is a company focused on the creation of real and functional solutions tailored specifically to our customers, using current and cutting-edge technologies resulting in innovative programs and applications.
Development of mobile applications, document digitalisation, software development
Description A company:
100% Mexican integrated by young entrepreneurs in search of improving the relationship of our customers with digital media.
Using current and cutting-edge technologies resulting in innovative programs and applications.

Mission:
We focus on the creation of real and functional digital solutions tailored specifically to our customers that provide technological improvements within the reach of each of them.
Email address: kelevrads@gmail.com

https://www.linkedin.com/company/kelevra-digital-solutions

Interactive Designer
https://www.linkedin.com/in/michgonzalezherrera

Owner
https://www.linkedin.com/in/juancaspro





Fernando Diaz Lombardo currently works at Kelevra Digital Solutions / BlackBox Technologies Fernando studied at Rigoletti Casa de Diseño and Fernando is located at Mexico City Area, Mexico.

The software industry is involved in the development, marketing, and sales and is multifaceted. Its scope ranges from personal computer applications, operating systems, network management tools, enterprise software, software applications, operating systems, and customized software. Computer software engineers apply the principles and techniques of computer science, engineering, and mathematical analysis to the design, development, testing, and evaluation of the software and the systems that enable computers to perform their many applications. The software industry includes businesses for development, maintenance and publication of software that are using different business models, mainly either license/maintenance based (on-premises) or Cloud based (such as SaaS, PaaS, IaaS, MaaS, AaaS, etc.).

kelevrads.com is ranked #6737021 in the world this means that kelevrads.comis not a very good website and you should optimize your site for search engines . The average home page load time is 1000 milliseconds, it is really fast. This site has a low Pagerank(0/10). IP address is 173.254.107.78, and its server is hosted at . Last updated on 17.04.2015.

http://www.kelevrads.com/sp/

http://kelevrads.com/cdom.php

http://kelevrads.com/kelevra_legal.php

https://www.google.com/amp/slideplayer.es/amp/1820227/

Updated cover and profile pics...

https://www.facebook.com/EnablingAsia/posts/1899024186842922

https://www.facebook.com/EnablingAsia/posts/1899024560176218:0

https://www.facebook.com/Buzzme.m8/posts/1007900479367323

ONE WORLD.
ONE SIMCARD.
.
Travel to more than 200 over countries with Buzzme World SIM
while enjoying the local rates. Stay connected wherever you are.
.
buzzme.com.my
Hello Center +6011-3400-4400 (Mon-Fri, 9am-6pm, except PH)
FB IG @buzzme.m8
T&C apply
.
#Buzzme #BuzzmeMy
#TravellingSIM #BuzzmMobile #SIMcard #SIM
#RewardingPrepaid #WorldSIM #Starterpack

During the third quarter of the fiscal year-ended 2017, FAGI re-engaged with Grupo Richard and shall continue the due diligence period to May 31, 2018.

FAGI executives continue working on the acquisition of all subsidiaries, technology and real estate holdings associated with Grupo Richard of these assets. Details about this acquisition and more can be found on the Full Alliance web site. www.fullalliance.com



Nov 28, 2017
Full Alliance Group, Inc. (OTCPK: FAGI), Announces Acquisition of Grupo Richard

LOS ANGELES, California, November 28, 2017: Full Alliance Group, Inc. (OTCPK: FAGI), a holding company, is pleased to announce that after re-engaging Grupo Richard over the past several weeks, the acquisition of all subsidiaries, technology and real estate holdings associated with Grupo Richard was approved, at which point the assets were transferred into escrow.
The assets which are now part of Full Alliance Group Inc., include an extensive real estate portfolio professionally appraised with a net equity of over $40 million dollars USD, and the companies listed below:
• Operadora de Servicios GRMS de RI de CV
• Grupo Internacional Richard S de RI de CV
• Grupo Richard y Lange SAPI de CV SA de CV, and • Asesores en Comercio ON de Mexico
Grupo Richard’s assets are diverse, with most prominent of which are oceanfront and both urban and suburban real estate holdings. In
addition, holdings include retail, construction and POS banking system.
FAGI executives are quite excited with the development potential of these assets, and already had discussions with investors from Asia and Central America prepared to assist with the growth of these new subsidiaries.
Details about this acquisition and more can be found on the Full Alliance web site. www.fullalliance.com

Sincerely,
Jacob Thomas
Chairman of the Board / CEO

http://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=28437

Thu, Mar 29, 2018 10:40 - Full Alliance Group, Inc. (FAGI: Pink Current) released their Attorney Letter with Respect to Current Information concerning . To read the complete report, please visit: http://www.otcmarkets.com/financialReportViewer?symbol=FAGI&id=189881.

March 29, 2018
Randall V. Brumbaugh OTC Markets Group, Inc. 304 Hudson St.
2nd Floor
New York, NY 10013
Re: Full Alliance Group, Inc. (FAGI); Opinion Letter re Adequate Current Information for the Period Ending December 31, 2017
Dear Sir/Madam:
This office has been retained by Full Alliance Group, Inc. (the “Company” or the “Issuer”), formerly Beverly Hills Group, Inc., for the sole purpose of rendering an opinion in connection with the adequacy of the Company’s public disclosure documents.
This opinion is solely for the information of the OTC Markets Group, Inc. (“OTC Markets”). OTC Markets is entitled to rely on this opinion in determining whether the Issuer has made adequate current information publicly available within the meaning of Rule 144(c)(2) under the Securities Act of 1933, as amended. This opinion is not to be quoted in whole or in part or otherwise referred to, nor is it to be filed with any governmental agency or other person without my prior written consent, except that OTC Markets has full and complete permission and rights to publish this correspondence through the OTC Disclosure and News Service for viewing by the public and regulators.
This correspondence will serve to verify that I am a U. S. resident and citizen and have been retained for the purpose of reviewing the current information supplied by the Issuer and rendering this opinion if I find that the current information meets the statutory requirements.
I am licensed to practice law before the United States Supreme Court, the Ninth Circuit Court of Appeals, the Northern District of California, the Eastern District of California, the Central District of California, the Southern District of California, the United States Tax Court, the Military Court of Appeals and all courts in the State of California. This opinion is limited to the federal laws of the United States of America. I do not express any opinion with respect to the Blue Sky or securities laws of any State or other jurisdiction.
I am permitted to practice before the Securities and Exchange Commission and have not been prohibited from practice thereunder.
In rendering this limited opinion, I have investigated such matters, examined corporate documents and had such discussions and/or communications with representatives of the Company as I have deemed necessary or appropriate for purposes of providing this opinion. In this examination I have assumed that (1) all information contained therein is true and correct, (2) all signatures (both manual and conformed) are genuine, (3) all documents submitted to me as originals were authentic, true and complete, (4) all documents submitted to me as copies were true and complete copies of the originals, (5) each natural person signing any document reviewed by me had the mental capacity and legal authority to do so, and (6) each conversation I had with any representative or agent of the Company was accurate and truthful in all material respects. Nothing came to my attention during the course of my investigation that led me to conclude that any document provided or made available to me was not genuine or authentic or that assertions made to me by representatives or agents of the Company were not true or were lacking in any material respect.
I have relied on information obtained from public sources, officers, management, agents and/or representatives of the Company, as well as other sources, and I have no reason, based on my information and belief, to reasonably doubt that these sources were not reliable. I know of no facts which would reasonably lead me to conclude that the opinion set forth herein is inaccurate in any material respect.
The Issuer has submitted, and I have reviewed in connection with the preparation of this correspondence, the following information posted to OTC Markets on the dates indicated:
Document
Annual Report (unaudited) for the period ending 12/31/17
Quarterly Report for the period ending 9/30/17
Quarterly Report (amended) for the period ending 6/30/17
Quarterly Report for the period ending 6/30/17 Annual Report (unaudited) for the period ending 12/31/16
Quarterly Report for the period ending 3/31/17
Annual Report (unaudited) for the period ending 12/31/16
Quarterly Report for the period ending 9/30/16 Quarterly Report for the period ending 6/30/16
Quarterly Report for the period ending 3/31/16
Annual Report (unaudited) for the period ending 12/31/15
Date Published March 29, 2018
November 15, 2017
August 8, 2017
August 8, 2017
May 15, 2017 May 15, 2017
March 31, 2017
November 14, 2016
August 15, 2016
May 15, 2016
March 27, 2016
The Company changed its name from Beverly Hills Group, Inc. to Full Alliance Group, Inc., effective April 10, 2017.
After reasonable investigation I have no reason to believe that, at the time such information was submitted to OTC Markets, the information contained any untrue statement of material fact or failed to state a material fact necessary in order to make any statement proffered, in light of the circumstances under which it was made, not misleading.
I assume no obligation to update or supplement this opinion letter to reflect any change in fact or law which may hereafter come to my attention.

I have reviewed the information posted by the Issuer and after reasonable investigation I am of the opinion that the information (i) constitutes “adequate current information” concerning the Issuer and is “publicly available” within the meaning of SEC Rule 144(c)(2) under the Securities Act of 1933, as amended; (ii) includes all of the information that a broker-dealer would be required to obtain from the Issuer to publish a quotation for the Issuer’s securities under SEC Rule 15c2-11 of the Securities Exchange Act of 1934, as amended; (iii) complies as to form with the OTC Markets Group’s Guidelines for Providing Adequate Current Information; and (iv) the Information has been posted through the OTC Disclosure and News Service.
This opinion does not alleviate the professional and personal responsibilities of brokers, dealers and investors to conduct their own professional and personal due diligence. In the event that any fact or information in any document I have reviewed and/or information I have received from the Issuer or any Issuer representative is determined not to be true or lacking in any material fact, this opinion shall be null and void. Jacob Thomas, an Officer and Director of the Issuer, is responsible for the preparation of the financial statements as well as the entire filing with OTC Markets up to and including the current filing. Based on my information and belief and conversations with Mr. Thomas and those familiar with him, he has started and developed successful companies. For all of 2017 to the present, Jacob Thomas had the overall responsibility for the preparation of financial statements as well as all filings with the OTC Markets and based on my information and belief Mr. Thomas been a very successful business man well versed in accounting and general financial matters and seems to have sufficient resources to acquire the assistance of any professional he deems necessary.
The Company’s transfer agent, Interwest Transfer Company, Inc., 2302 Nash Street, 1981 Murray Holladay Rd., Salt Lake City, UT 84117, is registered with the SEC. I have relied on information provided to me by the Issuer and/or agents of the Issuer to confirm the number of shares outstanding.
I have (i) personally conferred with the Issuer’s management and a majority of the directors, (ii) reviewed the information published by the Issuer through the OTC Disclosure and News Service, and (iii) discussed the information with management and a majority of the directors of the Issuer.
To the best of my knowledge, after inquiry of the Issuer’s management and directors, neither the Company, any 5% holder of the company’s securities, nor counsel, is currently under investigation by any federal or state regulatory authority for any violation of federal or state securities laws.
Respectfully submitted, Randall V. Brumbaugh
cc: Full Alliance Group, Inc.

8780 19th St., Suite 450, Alta Loma, CA 91701 Voice (626) 335-7750

Apparently not yet...

Can’t operate without them...

Through its advertising partner, http://www.admaximizer.com the platform utilizes engaging formats, ad serving, mediation, and programmatic video advertising across desktop and mobile screens which enables CannaNet.TV to support video ads from all Advertisers regardless if they have transitioned to HTML5 or still utilize Flash through this single tag solution.

Kush Processing has taken the long and educational road coming into being. We are fortunate enough to have a core group of business associates at TSMI who have decades of experience with industries that have had their share of legislative challenges. We have the faith and determination to find revolutionary insights when others seem to be content to offer patchwork solutions or sit back and wait. The banks that we work with have serviced online gaming, off-track betting, payday lenders, call centers, monthly membership programs and just about any other high-risk merchant.